<DOC>
	<DOCNO>NCT02743871</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics , pharmacodynamics PF-06817024 healthy volunteer may mildly atopic participant chronic rhinosinusitis nasal polyp</brief_summary>
	<brief_title>Study Of PF-06817024 In Healthy Subjects And In Patients With Chronic Rhinosinusitis With Nasal Polyps</brief_title>
	<detailed_description />
	<mesh_term>Polyps</mesh_term>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Nasal Polyps</mesh_term>
	<criteria>Inclusion Criteria Healthy male subject , healthy female subject nonchildbearing potential , 1855 year age ( Part 1 ) Male subject , female subject nonchildbearing potential , female subject childbearing potential documented bilateral tubal ligation ( tubes tie ) bilateral salpingectomy ( tubes remove ) , 1865 year age , 2 follow symptom : nasal congestion/obstruction , nasal discharge , face pain/pressure , reduction/loss smell ( Part 2 ) Clinically significant disease ( cardiac , psychiatric , autoimmune , renal , etc . ) , positive urine drug test , fever within 7 day dose , active infection within 28 day dose ( Part 1 2 ) History allergic reaction topical lidocaine , nasal surgery within 6 month ( Part 2 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>FIH , Pharmacokinetics</keyword>
</DOC>